NEW YORK, Nov. 9, 2022 /PRNewswire/ — The bromhidrosis disease treatment market size is expected to grow by USD 362.76 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 8.92% during the forecast period, according to Technavio. The market has been segmented by type geography (North America, Europe, Asia, and Rest of World (ROW) and (apocrine body odor and eccrine body odor). Get a comprehensive report summary that describes the market size and forecast along with research methodology. The FREE sample report is available in PDF format

The rise in the number of patients affected by diabetes and kidney diseases, government awareness programs about the disease, and an increase in healthcare affordability in the US are some of the major factors propelling the market growth. However, factors such as the high cost of treatment, rise in the cost of R&D activities, and lack of knowledge of the disease will hamper the market growth.

More details: https://www.technavio.com/report/bromhidrosis-disease-treatment-market-industry-analysis

Bromhidrosis Disease Treatment Market: Trend

The increasing M&As is a key trend shaping the bromhidrosis disease treatment market. The key vendors are acquiring small vendors to gain access to new products and technologies at low costs. For instance, in February 2022, Ipsen Pharma partnered with Mayoly Spindler to sell its global consumer healthcare business. In May 2022, Pfizer Inc. announced the acquisition of Biohaven Pharmaceutical Holding Company Ltd. In January 2022, Novartis AG partnered with Alnylam to work on targeted therapy to restore liver function. Thus, the rise in the number of M&A will support the growth of the market in the coming years.

Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. Buy Now for detailed information about market dynamics

Bromhidrosis Disease Treatment Market: Type Landscape

By type, the apocrine body odor segment will be a significant contributor to market growth during the forecast period. Apocrine sweat, when discharged, is colorless and odorless. In apocrine bromhidrosis, body odor is caused due to the combination of lipid-rich apocrine gland perspiration with microorganisms on the skin. This leads to the formation of thioalcohol. Thus, the increase in the number of people with apocrine bromhidrosis will drive the growth of the segment during the forecast period.

Bromhidrosis Disease Treatment Market: Geographic Landscape

By geography, North America is going to have lucrative growth during the forecast period. About 38% of the market’s overall growth is expected to originate from the region. The US and Canada are the key markets for bromhidrosis disease treatment in North America. The growth of the market in the region is attributed to factors such as rising healthcare expenditures, a well-developed healthcare sector, a large patient population, and government backing for R&D.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report

Bromhidrosis Disease Treatment Market: Companies Covered

• AbbVie Inc. – The company offers bromhidrosis disease treatment, namely Botox.
• Galderma SA – The company offers bromhidrosis disease treatment, namely Alluzience.
• Hikma Pharmaceuticals Plc – The company offers bromhidrosis disease treatment, namely Glycopyrrolate injection.
• Ipsen Pharma – The company offers bromhidrosis disease treatment, namely Dysport.
• Biovencer Healthcare Pvt. Ltd.
• Johnson & Johnson – The company offers bromhidrosis disease treatment, namely Ditropan XL, through its subsidiary Janssen.
• Boehringer Ingelheim International GmbH
• Journey Medical Corp.
• Medytox Inc.
• Merz Pharma GmbH & Co. KGaA
• Novartis AG
• Pfizer Inc.

Bromhidrosis Disease Treatment Market: What our reports offer

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers market data from 2021 to 2026
• Market trends (threats, challenges, drivers, investment opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping recording the key common trends
• Company profiling with financials, detailed strategies, and recent developments
• Supply chain trends mapping the latest technological advancements

Get lifetime access to our Technavio Insights! Subscribe to our Basic Plan billed annually at USD 5000

Related Reports

Gastrointestinal Diseases Therapeutics Market by Drug Class and Geography – Forecast and Analysis 2022-2026: The increasing incidence of gastrointestinal diseases is driving market growth. Gastrointestinal diseases have increased significantly across the globe. Improper diet, inactive lifestyle, stress, food sensitivity, and bacterial or viral infection are the major factors contributing to the increasing incidence of chronic and acute gastrointestinal diseases.

Celiac Diseases Drugs Market by Therapy Type and Geography – Forecast and Analysis 2022-2026: Higher consumption of gluten-containing food is driving the market growth. Celiac disease is characterized by an increase in gluten deposition in the body due to the high consumption of food containing gluten. Pizza, cake, soups, beer, bread, cookies, pasta, and burgers are some of the widely consumed food that contains gluten.

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary 
• Exhibit 17: Five forces analysis – Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry 
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition 
• Exhibit 23: Chart on Market condition – Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments 
• Exhibit 24: Chart on Type – Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type – Market share 2021-2026 (%)

• 5.2 Comparison by Type 
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type

• 5.3 Apocrine body odor – Market size and forecast 2021-2026
• Exhibit 28: Chart on Apocrine body odor – Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Apocrine body odor – Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Apocrine body odor – Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Apocrine body odor – Year-over-year growth 2021-2026 (%)

• 5.4 Eccrine body odor – Market size and forecast 2021-2026
• Exhibit 32: Chart on Eccrine body odor – Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Eccrine body odor – Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Eccrine body odor – Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Eccrine body odor – Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by Type 
• Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 38: Chart on Market share by geography 2021-2026 (%)
• Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison

• 7.3 North America – Market size and forecast 2021-2026
• Exhibit 42: Chart on North America – Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America – Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America – Year-over-year growth 2021-2026 (%)

• 7.4 Europe – Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe – Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe – Year-over-year growth 2021-2026 (%)

• 7.5 Asia – Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia – Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia – Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)

• 7.7 US – Market size and forecast 2021-2026
• Exhibit 58: Chart on US – Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US – Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US – Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US – Year-over-year growth 2021-2026 (%)

• 7.8 Canada – Market size and forecast 2021-2026
• Exhibit 62: Chart on Canada – Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Canada – Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Canada – Year-over-year growth 2021-2026 (%)

• 7.9 Germany – Market size and forecast 2021-2026
• Exhibit 66: Chart on Germany – Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Germany – Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Germany – Year-over-year growth 2021-2026 (%)

• 7.10 China – Market size and forecast 2021-2026
• Exhibit 70: Chart on China – Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on China – Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on China – Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on China – Year-over-year growth 2021-2026 (%)

• 7.11 UK – Market size and forecast 2021-2026
• Exhibit 74: Chart on UK – Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK – Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK – Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK – Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.3 Impact of drivers and challenges 
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026

9 Vendor Landscape

• 9.2 Vendor landscape 
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption 
• Exhibit 81: Overview on factors of disruption

• 9.4 Industry risks 
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered 
• Exhibit 83: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 84: Matrix on vendor position and classification

• 10.3 AbbVie Inc. 
• Exhibit 85: AbbVie Inc. – Overview
• Exhibit 86: AbbVie Inc. – Product / Service
• Exhibit 87: AbbVie Inc. – Key offerings

• 10.4 Boehringer Ingelheim International GmbH
• Exhibit 88: Boehringer Ingelheim International GmbH – Overview
• Exhibit 89: Boehringer Ingelheim International GmbH – Business segments
• Exhibit 90: Boehringer Ingelheim International GmbH – Key news
• Exhibit 91: Boehringer Ingelheim International GmbH – Key offerings
• Exhibit 92: Boehringer Ingelheim International GmbH – Segment focus

• 10.5 Galderma SA 
• Exhibit 93: Galderma SA – Overview
• Exhibit 94: Galderma SA – Product / Service
• Exhibit 95: Galderma SA – Key news
• Exhibit 96: Galderma SA – Key offerings

• 10.6 Hikma Pharmaceuticals Plc 
• Exhibit 97: Hikma Pharmaceuticals Plc – Overview
• Exhibit 98: Hikma Pharmaceuticals Plc – Business segments
• Exhibit 99: Hikma Pharmaceuticals Plc – Key offerings
• Exhibit 100: Hikma Pharmaceuticals Plc – Segment focus

• 10.7 Ipsen Pharma 
• Exhibit 101: Ipsen Pharma – Overview
• Exhibit 102: Ipsen Pharma – Business segments
• Exhibit 103: Ipsen Pharma – Key offerings
• Exhibit 104: Ipsen Pharma – Segment focus

• 10.8 Johnson and Johnson 
• Exhibit 105: Johnson and Johnson – Overview
• Exhibit 106: Johnson and Johnson – Business segments
• Exhibit 107: Johnson and Johnson – Key news
• Exhibit 108: Johnson and Johnson – Key offerings
• Exhibit 109: Johnson and Johnson – Segment focus

• 10.9 Medytox Inc. 
• Exhibit 110: Medytox Inc. – Overview
• Exhibit 111: Medytox Inc. – Product / Service
• Exhibit 112: Medytox Inc. – Key offerings

• 10.10 Merz Pharma GmbH and Co. KGaA 
• Exhibit 113: Merz Pharma GmbH and Co. KGaA – Overview
• Exhibit 114: Merz Pharma GmbH and Co. KGaA – Product / Service
• Exhibit 115: Merz Pharma GmbH and Co. KGaA – Key offerings

• 10.11 Novartis AG 
• Exhibit 116: Novartis AG – Overview
• Exhibit 117: Novartis AG – Business segments
• Exhibit 118: Novartis AG – Key offerings
• Exhibit 119: Novartis AG – Segment focus

• 10.12 Pfizer Inc. 
• Exhibit 120: Pfizer Inc. – Overview
• Exhibit 121: Pfizer Inc. – Product / Service
• Exhibit 122: Pfizer Inc. – Key news
• Exhibit 123: Pfizer Inc. – Key offerings

11 Appendix

• 11.2 Inclusions and exclusions checklist 
• Exhibit 124: Inclusions checklist
• Exhibit 125: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 126: Currency conversion rates for US$

• 11.4 Research methodology 
• Exhibit 127: Research methodology
• Exhibit 128: Validation techniques employed for market sizing
• Exhibit 129: Information sources

• 11.5 List of abbreviations 
• Exhibit 130: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio